147 related articles for article (PubMed ID: 27191615)
1. 2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors.
Kim BK; Ko H; Jeon ES; Ju ES; Jeong LS; Kim YC
Eur J Med Chem; 2016 Sep; 120():202-16. PubMed ID: 27191615
[TBL] [Abstract][Full Text] [Related]
2. Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease.
Kim BK; Cho JH; Jeong P; Lee Y; Lim JJ; Park KR; Eom SH; Kim YC
FEBS Lett; 2015 Jul; 589(15):1795-801. PubMed ID: 26022398
[TBL] [Abstract][Full Text] [Related]
3. Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.
Jung E; Lee JY; Kim HJ; Ryu CK; Lee KI; Kim M; Lee CK; Go YY
Bioorg Med Chem Lett; 2018 Aug; 28(14):2533-2538. PubMed ID: 29866517
[TBL] [Abstract][Full Text] [Related]
4. Development of anti-coxsackievirus agents targeting 3C protease.
Kim BK; Kim JH; Kim NR; Lee WG; Lee SD; Yun SH; Jeon ES; Kim YC
Bioorg Med Chem Lett; 2012 Nov; 22(22):6952-6. PubMed ID: 23062551
[TBL] [Abstract][Full Text] [Related]
5. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.
Lim BK; Yun SH; Ju ES; Kim BK; Lee YJ; Yoo DK; Kim YC; Jeon ES
Virus Res; 2015 Mar; 199():1-8. PubMed ID: 25485472
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
7. New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling.
Kassem AF; Batran RZ; Abbas EMH; Elseginy SA; Shaheen MNF; Elmahdy EM
Eur J Med Chem; 2019 Apr; 168():447-460. PubMed ID: 30844608
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors.
Ramajayam R; Tan KP; Liu HG; Liang PH
Bioorg Med Chem; 2010 Nov; 18(22):7849-54. PubMed ID: 20947359
[TBL] [Abstract][Full Text] [Related]
9. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
[TBL] [Abstract][Full Text] [Related]
10. Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity.
Abdel-Mageed WM; Bayoumi SA; Chen C; Vavricka CJ; Li L; Malik A; Dai H; Song F; Wang L; Zhang J; Gao GF; Lv Y; Liu L; Liu X; Sayed HM; Zhang L
Bioorg Med Chem; 2014 Apr; 22(7):2236-43. PubMed ID: 24613627
[TBL] [Abstract][Full Text] [Related]
11. Development of potent inhibitors of the coxsackievirus 3C protease.
Lee ES; Lee WG; Yun SH; Rho SH; Im I; Yang ST; Sellamuthu S; Lee YJ; Kwon SJ; Park OK; Jeon ES; Park WJ; Kim YC
Biochem Biophys Res Commun; 2007 Jun; 358(1):7-11. PubMed ID: 17485072
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors.
Zeng D; Ma Y; Zhang R; Nie Q; Cui Z; Wang Y; Shang L; Yin Z
Bioorg Med Chem Lett; 2016 Apr; 26(7):1762-6. PubMed ID: 26916437
[TBL] [Abstract][Full Text] [Related]
13. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
[TBL] [Abstract][Full Text] [Related]
14. N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection.
Jagdeo JM; Dufour A; Klein T; Solis N; Kleifeld O; Kizhakkedathu J; Luo H; Overall CM; Jan E
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437971
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of N-benzenesulfonyl matrinic acid derivatives as a novel class of coxsackievirus B3 inhibitors.
Wang SG; Kong LY; Li YH; Cheng XY; Su F; Tang S; Bi CW; Jiang JD; Li YH; Song DQ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3690-3. PubMed ID: 26112440
[TBL] [Abstract][Full Text] [Related]
16. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.
Tan J; George S; Kusov Y; Perbandt M; Anemüller S; Mesters JR; Norder H; Coutard B; Lacroix C; Leyssen P; Neyts J; Hilgenfeld R
J Virol; 2013 Apr; 87(8):4339-51. PubMed ID: 23388726
[TBL] [Abstract][Full Text] [Related]
17. Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.
Wang HM; Liang PH
Expert Opin Ther Pat; 2010 Jan; 20(1):59-71. PubMed ID: 20021285
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease.
Tan YW; Ang MJ; Lau QY; Poulsen A; Ng FM; Then SW; Peng J; Hill J; Hong WJ; Chia CS; Chu JJ
Sci Rep; 2016 Sep; 6():33663. PubMed ID: 27645381
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.
Shang L; Zhang S; Yang X; Sun J; Li L; Cui Z; He Q; Guo Y; Sun Y; Yin Z
Antimicrob Agents Chemother; 2015 Apr; 59(4):1827-36. PubMed ID: 25421478
[TBL] [Abstract][Full Text] [Related]
20. Toward development of generic inhibitors against the 3C proteases of picornaviruses.
Banerjee K; Bhat R; Rao VUB; Nain A; Rallapalli KL; Gangopadhyay S; Singh RP; Banerjee M; Jayaram B
FEBS J; 2019 Feb; 286(4):765-787. PubMed ID: 30461192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
